Wang Y, Chen Z, Wei B, Zhang R, Zhang X, Xu W
Sci Rep. 2025; 15(1):6287.
PMID: 39984596
PMC: 11845672.
DOI: 10.1038/s41598-025-90667-z.
Liang Y, Ye X, Pan M, Chen Y, Yuan Y, Luo L
BMC Gastroenterol. 2025; 25(1):75.
PMID: 39934679
PMC: 11818238.
DOI: 10.1186/s12876-025-03661-0.
Huang X, Zhang X, Hao X, Wang T, Wu P, Shen L
Front Nutr. 2025; 12:1507342.
PMID: 39917744
PMC: 11798782.
DOI: 10.3389/fnut.2025.1507342.
Lee E, Kim J, Yoon S
J Clin Med. 2025; 14(2).
PMID: 39860549
PMC: 11765748.
DOI: 10.3390/jcm14020542.
Saberian A, Dehghan A, Homayounfar R, Kaffashan S, Zarei F, Niknejad S
BMC Gastroenterol. 2024; 24(1):443.
PMID: 39623301
PMC: 11610269.
DOI: 10.1186/s12876-024-03535-x.
Associations between MASLD, atrial fibrillation, cardiovascular events, mortality and aspirin use in older adults.
Clayton-Chubb D, Roberts S, Majeed A, Woods R, Tonkin A, Nelson M
Geroscience. 2024; 47(1):1303-1318.
PMID: 39607592
PMC: 11872849.
DOI: 10.1007/s11357-024-01435-2.
The mediation effect of liver and anthropometric indices on the relationship between incidence of diabetes and physical activity: results of 5-year follow up azar cohort study.
Haghshenas R, Gilani N, Somi M, Faramarzi E
BMC Public Health. 2024; 24(1):3190.
PMID: 39558270
PMC: 11572127.
DOI: 10.1186/s12889-024-20587-6.
Protective Effect of High Adherence to Mediterranean Diet on the Risk of Incident Type-2 Diabetes in Subjects with MAFLD: The Di@bet.es Study.
Lago-Sampedro A, Oualla-Bachiri W, Garcia-Serrano S, Maldonado-Araque C, Valdes S, Doulatram-Gamgaram V
Nutrients. 2024; 16(21).
PMID: 39519621
PMC: 11548257.
DOI: 10.3390/nu16213788.
Increased risk of vascular complications in patients with type 2 diabetes and fatty liver disease.
Sun W, Liu D, Yang T, Zhou Z, Li D, Zhao Z
BMC Endocr Disord. 2024; 24(1):235.
PMID: 39497118
PMC: 11536858.
DOI: 10.1186/s12902-024-01766-3.
External Validation of Serologic Scores for the Detection of Liver Steatosis Among People With HIV.
Riebensahm C, Brocker J, Berzigotti A, Gunthard H, Tarr P, Furrer H
Open Forum Infect Dis. 2024; 11(9):ofae411.
PMID: 39282634
PMC: 11398894.
DOI: 10.1093/ofid/ofae411.
Investigating the Association between Steatotic Liver Disease and CKD in a Nationally Representative Sample.
Lai M, Lai J, Allegretti A, Patidar K, Cullaro G
Kidney360. 2024; 5(12):1844-1852.
PMID: 39235870
PMC: 11687990.
DOI: 10.34067/KID.0000000569.
Non-Invasive Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease in Adolescents with Severe Obesity; Patient Characteristics and Association with Leptin-A Cross-Sectional Overview of Baseline Data from a RCT.
de Boom F, Talib A, Roebroek Y, Paulus G, Koek G, Robben S
Children (Basel). 2024; 11(8).
PMID: 39201901
PMC: 11352657.
DOI: 10.3390/children11080965.
Automated machine learning models for nonalcoholic fatty liver disease assessed by controlled attenuation parameter from the NHANES 2017-2020.
Liu L, Lin J, Liu L, Gao J, Xu G, Yin M
Digit Health. 2024; 10:20552076241272535.
PMID: 39119551
PMC: 11307367.
DOI: 10.1177/20552076241272535.
Association between composite dietary antioxidant index and metabolic dysfunction associated steatotic liver disease: result from NHANES, 2017-2020.
Zhang Z, Wang H, Chen Y
Front Nutr. 2024; 11:1412516.
PMID: 39104752
PMC: 11299214.
DOI: 10.3389/fnut.2024.1412516.
The fatty liver index and risk of incident venous thromboembolism: the Tromsø Study.
Scheres L, Braekkan S, Verlaan J, Cannegieter S, Hansen J, Morelli V
Res Pract Thromb Haemost. 2024; 8(4):102447.
PMID: 38953053
PMC: 11215415.
DOI: 10.1016/j.rpth.2024.102447.
Association of MAFLD and MASLD with all-cause and cause-specific dementia: a prospective cohort study.
Bao X, Kang L, Yin S, Engstrom G, Wang L, Xu W
Alzheimers Res Ther. 2024; 16(1):136.
PMID: 38926784
PMC: 11201326.
DOI: 10.1186/s13195-024-01498-5.
The Link between Abdominal Obesity Indices and the Progression of Liver Fibrosis: Insights from a Population-Based Study.
Julian M, Arteaga I, Toran-Monserrat P, Pera G, Perez-Montes de Oca A, Ruiz-Rojano I
Nutrients. 2024; 16(11).
PMID: 38892518
PMC: 11174397.
DOI: 10.3390/nu16111586.
Dietary and genetic determinants of non-alcoholic fatty liver disease in coronary heart disease patients.
Heerkens L, Geleijnse J, van Duijnhoven F
Eur J Nutr. 2024; 63(5):1847-1856.
PMID: 38864867
PMC: 11329394.
DOI: 10.1007/s00394-024-03431-w.
The independent and joint associations of vitamin B12 and methylmalonic acid on the risk of mortality in individuals with metabolic dysfunction-associated steatotic liver disease.
Wang P, Yu J, Zhao Y, Simayi R, Shi D
Eur J Nutr. 2024; 63(7):2541-2553.
PMID: 38864864
DOI: 10.1007/s00394-024-03448-1.
Validation of Nutritional Approaches to Modulate Cardiovascular and Diabetic Risk Factors in Patients with Hypertriglyceridemia or Prediabetes-The MoKaRi II Randomized Controlled Study.
Braun T, Drobner T, Kipp K, Kiehntopf M, Schlattmann P, Lorkowski S
Nutrients. 2024; 16(9).
PMID: 38732508
PMC: 11085300.
DOI: 10.3390/nu16091261.